Zdrowie i gospodarka · 26/06/2002

FDA Revokes Regulation for Digoxin Oral Use Products

The FDA is revoking the regulation for marketing digoxin products for oral use, as these new drugs can be regulated under the approval process for new drug applications and abbreviated new drug applications, as outlined in the Federal Food, Drug, and Cosmetic Act.